UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Timing of antiretroviral therapy in relation to co-morbidities

International journal of infectious diseases, 2014-04, Vol.21 (S1), p.31-31

Gulick, R

2014

Volltextzugriff (PDF)

New antiretroviral drugs

Clinical microbiology and infection, 2003-03, Vol.9 (3), p.186-193

Gulick, R.M.

2003

Volltextzugriff (PDF)

Co-localization of three gonadotropin-releasing hormone transcripts in larval, parasitic, and adult sea lamprey brains

General and comparative endocrinology, 2018-08, Vol.264, p.84-93

2018

Volltextzugriff (PDF)

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study

AIDS (London), 2004-12, Vol.18 (18), p.2391-2400

2004

Volltextzugriff (PDF)

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

The New England journal of medicine, 1997-09, Vol.337 (11), p.734-739

1997

Volltextzugriff (PDF)

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

The New England journal of medicine, 2004-04, Vol.350 (18), p.1850-1861

2004

Volltextzugriff (PDF)

Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

Clinical infectious diseases, 2006-02, Vol.42 (3), p.401-407

2006

Volltextzugriff (PDF)

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Annals of internal medicine, 2000-07, Vol.133 (1), p.35

2000

Volltextzugriff (PDF)

Raltegravir: The First HIV Type 1 Integrase Inhibitor

Clinical infectious diseases, 2009-04, Vol.48 (7), p.931-939

2009

Volltextzugriff (PDF)

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

JAMA : the journal of the American Medical Association, 1998-07, Vol.280 (1), p.35

1998

Volltextzugriff (PDF)

Short-Term Safety and Antiretroviral Activity of T-1249, a Second-Generation Fusion Inhibitor of HIV

The Journal of infectious diseases, 2004-03, Vol.189 (6), p.1075-1083

2004

Volltextzugriff (PDF)

Sex-Based Differences in Saquinavir Pharmacology and Virologic Response in AIDS Clinical Trials Group Study 359

The Journal of infectious diseases, 2004-04, Vol.189 (7), p.1176-1184

2004

Volltextzugriff (PDF)

Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1943-1949

2005

Volltextzugriff (PDF)

Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease

Annals of internal medicine, 1998-10, Vol.129 (7), p.573

1998

Volltextzugriff (PDF)

Randomized Study of Saquinavir with Ritonavir or Nelfinavir Together with Delavirdine, Adefovir, or Both in Human Immunodeficiency Virus—Infected Adults with Virologic Failure on Indinavir: AIDS Clinical Trials Group Study 359

The Journal of infectious diseases, 2000-11, Vol.182 (5), p.1375-1384

2000

Volltextzugriff (PDF)

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial

JAMA : the journal of the American Medical Association, 2002-07, Vol.288 (2), p.169

2002

Volltextzugriff (PDF)

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

The Journal of infectious diseases, 2007-07, Vol.196 (2), p.304-312

2007

Volltextzugriff (PDF)

Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse-Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Protease Inhibitor-Experienced Patients

The Journal of infectious diseases, 2002-03, Vol.185 (5), p.599-607

2002

Volltextzugriff (PDF)

Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258

Annals of internal medicine, 1999-03, Vol.130 (6), p.510

1999

Volltextzugriff (PDF)

Initiation and sequencing of ART

Journal of the International AIDS Society, 2013-06, Vol.16 (Suppl 1)

Gulick, R

2013

Volltextzugriff (PDF)

The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol 850)

The Journal of infectious diseases, 2000-05, Vol.181 (5), p.1622-1628

2000

Volltextzugriff (PDF)

Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection

The Journal of infectious diseases, 1999-04, Vol.179 (4), p.808-816

1999

Volltextzugriff (PDF)

Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents

AIDS (London), 1998, Vol.12 Suppl 3, p.S17-S22

Gulick, R

1998

Volltextzugriff (PDF)

HAART roll‐out in the new fiscal and economic environment

Journal of the International AIDS Society, 2012-11, Vol.15 (S4), p.1-1

Gulick, R

2012

Volltextzugriff (PDF)

Preexisting Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz-Based Regimen in Treatment-Naive HIV-1–Infected Subjects

The Journal of infectious diseases, 2008-03, Vol.197 (6), p.867-870

2008

Volltextzugriff (PDF)

1 – 25 von 552

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(472)
Mit Volltextzugriff
(421)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(548)
Deutsch
(3)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(346)
Life Sciences & Biomedicine
(246)
Humans
(180)
Biological And Medical Sciences
(118)
Male
(113)
Infectious Diseases
(102)
Female
(97)
Medical Sciences
(96)
Hiv Infections - Drug Therapy
(89)
Adult
(86)
Physical Sciences
(76)
Immunology
(72)
Hiv
(70)
Human Viral Diseases
(62)
Viral Diseases
(62)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(61)
Human Immunodeficiency Virus
(60)
Microbiology
(59)
Virology
(55)
Animals
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Timing of antiretroviral therapy in relation to co-morbidities

New antiretroviral drugs

Co-localization of three gonadotropin-releasing hormone transcripts in larval, parasitic, and adult sea lamprey brains

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Raltegravir: The First HIV Type 1 Integrase Inhibitor

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

Short-Term Safety and Antiretroviral Activity of T-1249, a Second-Generation Fusion Inhibitor of HIV

Sex-Based Differences in Saquinavir Pharmacology and Virologic Response in AIDS Clinical Trials Group Study 359

Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease

Randomized Study of Saquinavir with Ritonavir or Nelfinavir Together with Delavirdine, Adefovir, or Both in Human Immunodeficiency Virus—Infected Adults with Virologic Failure on Indinavir: AIDS Clinical Trials Group Study 359

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse-Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Protease Inhibitor-Experienced Patients

Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258

Initiation and sequencing of ART

The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol 850)

Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection

Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents

HAART roll‐out in the new fiscal and economic environment

Preexisting Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz-Based Regimen in Treatment-Naive HIV-1–Infected Subjects

Suchergebnisse filtern